Treatment and Trial Options

Clinical trials are research studies that involve people. Any time you or a loved one need treatment for cancer, clinical trials are an option to think about. Learning all you can about clinical trials can help you talk with your doctor and decide what is right for you.

We want to provide you with up-to-date, credible information about clinical trials. Information on this page is from the National Cancer Institute (NCI) and the National Institutes of Health (NIH).

Making your personalized care plan

Your doctors will help you make the plan that is best for you based on a good evaluation of your cancer, your general health and your preferences.

Understanding more about the treatment options, both the surgical and drug treatment options that may be discussed, will help you during your initial appointments.

For some patients the only treatment they need is surgery. For others, surgery is not suggested for the treatment plan. The test information will guide the discussion but this short video for kidney cancer is a must watch before your consultations with the urologist and urologic surgeon.

Active Surveillance: Is it safe to watch small renal masses?

“Active Surveillance” is sometimes mentioned as an option especially for a small mass. Two informative videos are provided for patients considering “Active Surveillance”.

Surgery:
Can you explain nephrectomy?

Dr. Eric Kauffman, MD, discusses the difference between partial and radical nephrectomy of kidney cancer.

What are histology and grade and stage of my kidney cancer? Why are they important?

The report on your biospy or nephrectomy contains important information on the type and stage of your cancer. Click to view this handout from IKCC which gives you the basics on how your testing may guide your care plan.

Understanding your pathology report: for clear cell, papillary and chromophobe subtypes

Clear Cell Renal Carcinoma

Clear cell renal cell carcinoma is the most common type of kidney cancer in adults.

Papillary renal cell carcinoma

Papillary renal cell carcinoma is the second most common type of kidney cancer in adults.

chromophobe renal cell carcinoma

Chromophobe renal cell carcinoma is the third most common type of kidney cancer in adults.

Download this useful document from the National Cancer Institute to read about taking part in a clinical research trial.

Connect with Our Communities

There are multiple support groups serving the kidney cancer community.  SmartPatients.com is a patient forum and a KidneyCAN partner. We recommend this as a private, moderated  place to talk with other patients.  Your cancer center may also have their own support groups.

Reliable  Resources for Cancer Information
NATIONAL CANCER INSTITUTE
www.cancer.gov
CANCER.NET
www.cancer.net/cancer-types/kidney-cancer
INTERNATIONAL KIDNEY CANCER COALITION
www.ikcc.org
CANCER AND CAREERS
www.cancerandcareers.org/en/at-work

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...